Israel vs Laos: Cause of death, by non-communicable diseases, ages 15-59, male
Israel
60.0%
in 2021
Laos
60.5%
in 2021
Israel rank
61st
Laos rank
58th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Israel
- Laos
How they compare
Laos currently reports 60.5% against 60.0% in Israel, a difference of 0.5%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Israel ahead.
Israel ranks 61st and Laos ranks 58th of 185 countries.
Israel has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Israel | Laos | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 65.9% | 50.6% | 15.3% | Israel |
| 2010s | 71.9% | 58.8% | 13.1% | Israel |
| 2020s | 64.7% | 62.9% | 1.8% | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Israel or Laos?
- Laos, at 60.5% against 60.0% in Israel as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Israel and Laos?
- 0.5%, with Laos ahead.
- How many years of comparable data are there for Israel and Laos?
- 6 years are reported by both, from 2000 to 2021.
- How do Israel and Laos rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Israel ranks 61st and Laos ranks 58th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.